vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
VIRTUS INVESTMENT PARTNERS, INC. is the larger business by last-quarter revenue ($199.5M vs $148.6M, roughly 1.3× Azenta, Inc.). VIRTUS INVESTMENT PARTNERS, INC. runs the higher net margin — 3.6% vs -10.4%, a 13.9% gap on every dollar of revenue. On growth, Azenta, Inc. posted the faster year-over-year revenue change (0.8% vs -4.1%). Over the past eight quarters, Azenta, Inc.'s revenue compounded faster (4.4% CAGR vs -5.7%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
AZTA vs VRTS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $148.6M | $199.5M |
| Net Profit | $-15.4M | $7.1M |
| Gross Margin | 42.9% | — |
| Operating Margin | -4.9% | 7.7% |
| Net Margin | -10.4% | 3.6% |
| Revenue YoY | 0.8% | -4.1% |
| Net Profit YoY | -15.7% | -78.1% |
| EPS (diluted) | $-0.34 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $148.6M | $208.0M | ||
| Q3 25 | $159.2M | $216.4M | ||
| Q2 25 | $143.9M | $210.5M | ||
| Q1 25 | $143.3M | $217.9M | ||
| Q4 24 | $147.4M | $233.5M | ||
| Q3 24 | $150.6M | $227.0M | ||
| Q2 24 | $144.3M | $224.4M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | $-15.4M | $33.9M | ||
| Q3 25 | $50.9M | $31.3M | ||
| Q2 25 | $-48.0M | $42.7M | ||
| Q1 25 | $-47.7M | $28.1M | ||
| Q4 24 | $-11.0M | $39.5M | ||
| Q3 24 | $-6.6M | $49.1M | ||
| Q2 24 | $-6.6M | $26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 42.9% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 46.2% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 46.7% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.8% | — |
| Q1 26 | — | 7.7% | ||
| Q4 25 | -4.9% | 19.1% | ||
| Q3 25 | 1.2% | 21.7% | ||
| Q2 25 | -1.3% | 21.5% | ||
| Q1 25 | -12.7% | 16.8% | ||
| Q4 24 | -5.9% | 21.7% | ||
| Q3 24 | -3.1% | 24.3% | ||
| Q2 24 | -4.9% | 19.7% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | -10.4% | 16.3% | ||
| Q3 25 | 32.0% | 14.5% | ||
| Q2 25 | -33.4% | 20.3% | ||
| Q1 25 | -33.3% | 12.9% | ||
| Q4 24 | -7.5% | 16.9% | ||
| Q3 24 | -4.4% | 21.6% | ||
| Q2 24 | -4.5% | 11.6% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $-0.34 | $5.15 | ||
| Q3 25 | $1.12 | $4.65 | ||
| Q2 25 | $-1.05 | $6.12 | ||
| Q1 25 | $-1.04 | $4.05 | ||
| Q4 24 | $-0.25 | $4.65 | ||
| Q3 24 | $-0.25 | $5.71 | ||
| Q2 24 | $-0.12 | $2.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $136.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $93.6B |
| Total Assets | $2.1B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $136.6M | ||
| Q4 25 | $336.6M | — | ||
| Q3 25 | $279.8M | — | ||
| Q2 25 | $270.0M | — | ||
| Q1 25 | $253.6M | — | ||
| Q4 24 | $377.5M | — | ||
| Q3 24 | $280.0M | — | ||
| Q2 24 | $336.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
| Q1 26 | — | $93.6B | ||
| Q4 25 | $1.7B | $934.0M | ||
| Q3 25 | $1.7B | $918.7M | ||
| Q2 25 | $1.7B | $896.4M | ||
| Q1 25 | $1.7B | $893.7M | ||
| Q4 24 | $1.7B | $897.5M | ||
| Q3 24 | $1.8B | $889.0M | ||
| Q2 24 | $2.0B | $868.7M |
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $4.3B | ||
| Q3 25 | $2.1B | $3.9B | ||
| Q2 25 | $2.0B | $3.7B | ||
| Q1 25 | $2.0B | $3.7B | ||
| Q4 24 | $2.0B | $4.0B | ||
| Q3 24 | $2.1B | $3.6B | ||
| Q2 24 | $2.3B | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | — |
| Free Cash FlowOCF − Capex | $14.7M | — |
| FCF MarginFCF / Revenue | 9.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $20.8M | $-67.2M | ||
| Q3 25 | $2.2M | $108.3M | ||
| Q2 25 | $25.8M | $75.8M | ||
| Q1 25 | $14.4M | $-3.8M | ||
| Q4 24 | $29.8M | $1.8M | ||
| Q3 24 | $17.7M | $69.1M | ||
| Q2 24 | $9.8M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $14.7M | $-74.1M | ||
| Q3 25 | $-5.7M | $106.9M | ||
| Q2 25 | $15.0M | $74.2M | ||
| Q1 25 | $7.0M | $-6.8M | ||
| Q4 24 | $22.0M | $-3.8M | ||
| Q3 24 | $8.3M | $68.7M | ||
| Q2 24 | $1.3M | $68.6M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | -35.6% | ||
| Q3 25 | -3.6% | 49.4% | ||
| Q2 25 | 10.4% | 35.2% | ||
| Q1 25 | 4.9% | -3.1% | ||
| Q4 24 | 15.0% | -1.6% | ||
| Q3 24 | 5.5% | 30.3% | ||
| Q2 24 | 0.9% | 30.6% |
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 3.3% | ||
| Q3 25 | 4.9% | 0.7% | ||
| Q2 25 | 7.5% | 0.7% | ||
| Q1 25 | 5.2% | 1.4% | ||
| Q4 24 | 5.3% | 2.4% | ||
| Q3 24 | 6.2% | 0.2% | ||
| Q2 24 | 5.9% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -1.99× | ||
| Q3 25 | 0.04× | 3.45× | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | -0.13× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |